Increased expression of fatty acid binding protein 4 and leptin in resident macrophages characterises atherosclerotic plaque rupture

Atherosclerosis

Volumn 226, Issue 1, 2013, Pages 74-81

  Lee, K ^a   Santibanez Koref, M ^a   Polvikoski, T ^a   Birchall, D ^b   Mendelow, A D ^b   Keavney, B ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Gene expression; Laser micro dissection; Macrophages; Microarray; Plaque rupture

Indexed keywords

ACETYLSALICYLIC ACID; ADIPOCYTOKINE; ANGIOTENSIN RECEPTOR ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID BINDING PROTEIN 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEPTIN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SUCCINATE DEHYDROGENASE;

ARTICLE; ATHEROSCLEROSIS; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; DOWN REGULATION; GENE EXPRESSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; MACROPHAGE; MACROPHAGE ACTIVATION; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

AGED; FATTY ACID-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LEPTIN; MACROPHAGES; MALE; PLAQUE, ATHEROSCLEROTIC; RUPTURE, SPONTANEOUS;

EID: 84871398534     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.037     Document Type: Article

References (39)

1. Virmani R., Kolodgie F.D., Burke A.P., Farb A., Schwartz S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 May, 20(5):1262-1275.
2. Bijnens A.P., Lutgens E., Ayoubi T., Kuiper J., Horrevoets A.J., Daemen M.J. Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics data. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 Jun., 26(6):1226-1235.
3. Di Taranto M.D., Morgante A., Bracale U.M., et al. Altered expression of inflammation-related genes in human carotid atherosclerotic plaques. Atherosclerosis 2012 Jan., 220(1):93-101.
4. Faber B.C., Cleutjens K.B., Niessen R.L., et al. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circulation Research 2001 Sep. 14, 89(6):547-554.
5. Randi A.M., Biguzzi E., Falciani F., et al. Identification of differentially expressed genes in coronary atherosclerotic plaques from patients with stable or unstable angina by cDNA array analysis. Journal of Thrombosis and Haemostasis 2003 Apr., 1(4):829-835.
6. Papaspyridonos M., Smith A., Burnand K.G., et al. Novel candidate genes in unstable areas of human atherosclerotic plaques. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 Aug., 26(8):1837-1844.
7. Ijas P., Nuotio K., Saksi J., et al. Microarray analysis reveals overexpression of CD163 and HO-1 in symptomatic carotid plaques. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 Jan., 27(1):154-160.
8. Vemuganti R., Dempsey R.J. Carotid atherosclerotic plaques from symptomatic stroke patients share the molecular fingerprints to develop in a neoplastic fashion: a microarray analysis study. Neuroscience 2005, 131(2):359-374.
9. Dahl T.B., Yndestad A., Skjelland M., et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 2007 Feb. 27, 115(8):972-980.
10. Puig O., Yuan J., Stepaniants S., et al. A gene expression signature that classifies human atherosclerotic plaque by relative inflammation status. Circulation: Cardiovascular Genetics 2011 Dec., 4(6):595-604.
11. Hellemans J., Mortier G., De Paepe A., Speleman F., Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biology 2007, 8(2):R19.
12. Su A.I., Wiltshire T., Batalov S., et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proceedings of the National Academy of Sciences of the United States of America 2004 Apr. 20, 101(16):6062-6067.
13. Tchkonia T., Lenburg M., Thomou T., et al. Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. American Journal of Physiology 2007 Jan., 292(1):E298-E307.
14. Cho H.J., Shashkin P., Gleissner C.A., et al. Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiological Genomics 2007 Apr. 24, 29(2):149-160.
15. Jura J., Wegrzyn P., Korostynski M., et al. Identification of interleukin-1 and interleukin-6-responsive genes in human monocyte-derived macrophages using microarrays. Biochimica et Biophysica Acta 2008 Jun-Jul, 1779(6-7):383-389.
16. Liu H., Shi B., Huang C.C., Eksarko P., Pope R.M. Transcriptional diversity during monocyte to macrophage differentiation. Immunology Letters 2008 Apr. 15, 117(1):70-80.
17. Hagg D.A., Jernas M., Wiklund O., et al. Expression profiling of macrophages from subjects with atherosclerosis to identify novel susceptibility genes. International Journal of Molecular Medicine 2008 Jun., 21(6):697-704.
18. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological). JSTOR 1995, 289-300.
19. Maere S., Heymans K., Kuiper M. BiNGO: a cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics (Oxford, England) 2005 Aug. 15, 21(16):3448-3449.
20. Zhang B., Kirov S., Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Research 2005 Jul. 1, 33:W741-W748.
21. Ionita M.G., Vink A., Dijke I.E., et al. High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 Aug., 29(8):1220-1227.
22. Makowski L., Brittingham K.C., Reynolds J.M., Suttles J., Hotamisligil G.S. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. The Journal of Biological Chemistry 2005 Apr. 1, 280(13):12888-12895.
23. Hotamisligil G.S. Endoplasmic reticulum stress and atherosclerosis. Nature Medicine 2010 Apr., 16(4):396-399.
24. Tesauro M., Thompson W.C., Moss J. Effect of staurosporine-induced apoptosis on endothelial nitric oxide synthase in transfected COS-7 cells and primary endothelial cells. Cell Death & Differentiation 2006 Apr., 13(4):597-606.
25. Erbay E., Babaev V.R., Mayers J.R., et al. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nature Medicine 2009 Nov. 29, 15(12):1383-1391.
26. Makowski L., Boord J.B., Maeda K., et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nature Medicine 2001 Jun., 7(6):699-705.
27. Yoo H.J., Kim S., Park M.S., et al. Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography. The Journal of Clinical Endocrinology & Metabolism 2011 Mar., 96(3):E488-E492.
28. Tuncman G., Erbay E., Hom X., et al. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proceedings of the National Academy of Sciences of the United States of America 2006 May 2, 103(18):6970-6975.
29. Furuhashi M., Tuncman G., Gorgun C.Z., et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 2007 Jun. 21, 447(7147):959-965.
30. Holm S., Ueland T., Dahl T.B., et al. Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke. PLoS ONE 2011, 6(12):e28785.
31. Peeters W., de Kleijn D.P.V., Vink A., et al. Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events. European Heart Journal 2011 Jul., 32(14):1758-1768.
32. Yang R., Barouch L.A. Leptin signaling and obesity: cardiovascular consequences. Circulation Research 2007 Sep. 14, 101(6):545-559.
33. Tesauro M., Canale M.P., Rodia G., et al. Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiology Research and Practice 2011, 2011:653182.
34. Leung Y.-M., Kwan C.-Y. Dual vascular effects of leptin via endothelium: hypothesis and perspective. The Chinese Journal of Physiology 2008 Feb. 29, 51(1):1-6.
35. Campia U., Tesauro M., Cardillo C. Human obesity and endothelium-dependent responsiveness. British Journal of Pharmacology 2012 Feb., 165(3):561-573.
36. Gaukrodger N., Mayosi B.M., Imrie H., et al. A rare variant of the leptin gene has large effects on blood pressure and carotid intima-medial thickness: a study of 1428 individuals in 248 families. Journal of Medical Genetics 2005 Jun., 42(6):474-478.
37. Cabrero A., Cubero M., Llaverias G., et al. Leptin down-regulates peroxisome proliferator-activated receptor gamma (PPAR-gamma) mRNA levels in primary human monocyte-derived macrophages. Molecular and Cellular Biochemistry 2005 Jul., 275(1-2):173-179.
38. Maya-Monteiro C.M., Almeida P.E., D'Avila H., et al. Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. The Journal of Biological Chemistry 2008 Jan. 25, 283(4):2203-2210.
39. Kjerrulf M., Berke Z., Aspegren A., et al. Reduced cholesterol accumulation by leptin deficient (ob/ob) mouse macrophages. Inflammation Research 2006 Jul., 55(7):300-309.